Bristol-Myers Squibb Co
XHAM:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
Charoen Pokphand Foods PCL
SET:CPF
|
TH |
|
Intel Corp
NASDAQ:INTC
|
US |
|
A
|
AMP Ltd
NZX:AMP
|
AU |
|
Copenhagen Airports A/S
F:KLH
|
DK |
|
V
|
Volkswagen AG
XMUN:VOW3
|
DE |
|
Wealth Minerals Ltd
XTSX:WML
|
CA |
|
U
|
US Neurosurgical Holdings Inc
OTC:USNU
|
US |
|
T
|
Ten Square Games SA
WSE:TEN
|
PL |
|
S
|
Starbucks Corp
HKEX:4337
|
US |
|
SmileDirectClub Inc
OTC:SDCCQ
|
US |
|
R
|
Royal Bank of Canada
NYSE:RY
|
CA |
|
C
|
CECO Environmental Corp
NASDAQ:CECO
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
E
|
Emira Property Fund
JSE:EMI
|
ZA |
|
B
|
BNP Paribas SA
DUS:BNP
|
FR |
|
Cisco Systems Inc
NASDAQ:CSCO
|
US |
|
K
|
Kardex Holding AG
SWB:KAX2
|
CH |
|
A
|
Aditya Infotech Ltd
NSE:CPPLUS
|
IN |
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
Core Scientific Inc
NASDAQ:CORZ
|
US |
|
Clariane SE
PAR:CLARI
|
FR |
|
S
|
Sensata Technologies Holding PLC
F:S94
|
US |
|
LKQ Corp
NASDAQ:LKQ
|
US |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 54.08 EUR with a low forecast of 28.62 EUR and a high forecast of 67.42 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
54.08
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 54.08 EUR with a low forecast of 28.62 EUR and a high forecast of 67.42 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 6%.
